Epizyme, Inc.
USD1.47
+0.00 (+0.00%)
CEO
Robert Bazemore
IPO Date
2013-05-31
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$1.49
Prev. Close
$1.47
Day Low
$1.47
Day High
$1.50
52W Low
$0.41
52W High
$5.80
| 215,494 |
| $0.00 |
| 16 Aug 2022 | MOTT DAVID M | director | U-Tender | Disposed | 215,494 | $1.45 |
| 16 Aug 2022 | MOTT DAVID M | director | U-Tender | Disposed | 106,959 | $1.45 |
| 16 Aug 2022 | MOTT DAVID M | director: | D-Return | Disposed | 8,994 | $0.00 |
| 16 Aug 2022 | GOLDFISCHER CARL | director | D-Return | Disposed | 13,060 | $1.45 |
| 16 Aug 2022 | GOLDFISCHER CARL | director: | D-Return | Disposed | 8,994 | $0.00 |
| 16 Aug 2022 | GOLDFISCHER CARL | director | D-Return | Disposed | 3,380,951 | $1.45 |
| 16 Aug 2022 | Bogle Grant C. | President and CEO | D-Return | Disposed | 84,170 | $0.00 |
| 16 Aug 2022 | Bogle Grant C. | director, officer: President and CEO | D-Return | Disposed | 84,170 | $1.45 |